Purdue Targets Sandoz Over OxyContin Patents
Purdue Pharma LP on Thursday launched a patent suit against Sandoz Inc. in New York, making the generic-drug maker the latest target of Purdue's efforts to protect the blockbuster pain medication...To view the full article, register now.
Already a subscriber? Click here to view full article